Rona Therapeutics, a Shanghai, China-based clinical stage platform company which specializes in nucleic acid drug research and development, raised $35M in Series A+ funding.
The...
AusperBio Therapeutics, Inc. and Ausper Biopharma Co., Ltd. (collectively AusperBio), a clinical-stage biotechnology company with operations in the USA and China, closed a $37m Series A financing round.
The round...
SHANGHAI and ORLANDO, June 20, 2024 – Ronovo Surgical, a Shanghai-based medical technology innovator developing novel surgical robotics for soft tissue procedures, announces the...
Gausium, a Shanghai, China-based company providing autonomous cleaning solutions, raised USD50M in Series D funding.
The backers were not disclosed.
The company intends to use the...
Optix, a Beijing, China-based XR tech startup, raised US$15M in funding.
The round was led by Primavera Venture Partners. Existing investors Lanchi Ventures also participated.
The...
Brise Pharmaceuticals Co., LTD., a Shanghai, China-based company specializing in innovative treatments for acute and chronic pain, recently completed Pre-A and Pre-A+ financing with...
D3 Bio, a JiangSu and Shanghai, China-based biotechnology company, received $40M in Investment from Medicxi.
The company intends to use the funds to accelerate the...
TCab Tech, a Shangai, China-based eVTOL aircraft developer raised additional $20M in Series A funding.
The round was led by an unnamed strategic investment fund...
Haomo, a Beijing, China-based provider of a driver assistance system, raised over RMB 100M in Series B1 funding.
Chengdu Wufa Private Equity Fund Management made...
NoahArk Tech Group, a Hong Kong-based company which operates in the decentralized finance (DeFi) sector, received a $2.4M investment from EOS Network.
Noahark.io is a...
Documents, a Chinese fragrance brand, received an investment from Ushopal.
The amount of the deal was not disclosed.
The company intends to use the investment to...
Avistone Biotechnology, a Beijing, China-based biotechnology company focused on precision oncology therapeutics, closed a Series B financing of ~$140 million USD.
The round was led...
